ONCT - Oncternal Therapeutics Inc. (ONCT) CEO James Breitmeyer on Q2 2021 Results - Earnings Call Transcript
Oncternal Therapeutics, Inc. (ONCT) Q2 2021 Results Earnings Conference Call August 05, 2021, 5:00 pm ET Company Participants Richard Vincent - Chief Financial Officer James Breitmeyer - President, Chief Executive Officer Salim Yazji - Chief Medical Officer Conference Call Participants Hartaj Singh - Oppenheimer Robert Burns - H.C. Wainwright Carl Byrnes - Northland Securities Kumar Raja - Brookline Capital Markets Presentation Operator Greetings and welcome to the Oncternal Therapeutics, Incorporated's second-quarter 2021 financial results call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator instructions]. As a reminder, this conference is being recorded. It is now my pleasure to introduce Richard Vincent, Chief Financial Officer. Thank you. You may begin. Richard Vincent Thank you Darryl. Good afternoon everyone and thank you for joining us today. Joining me on this call this afternoon are our President and CEO, Dr. James Breitmeyer
For further details see:
Oncternal Therapeutics, Inc. (ONCT) CEO James Breitmeyer on Q2 2021 Results - Earnings Call Transcript